-
AI, Machine Learning & Computational Biology2 weeks agoAI Learns Cervical Cancer’s Signature to Stay Sharp Across Hospitals
A new iScience study introduces CSCC-PAG, a deep learning framework that combines domain-specific pre-training with self-supervised domain adaptation to improve cervical squamous cell carcinoma diagnosis across...
-
AI, Machine Learning & Computational Biology2 weeks agoDanaher, Nvidia Combine Lab Instrumentation and AI to Advance Autonomous Science
Danaher and Nvidia are collaborating to advance autonomous science, combining lab instrumentation, automation, and software with accelerated computing and AI so that experiments inform models and...
-
AI, Machine Learning & Computational Biology2 weeks agoAI designs working molecular scissors that recognize and cut selected protein targets
Proteases are naturally occurring enzymes that break down proteins into peptides and even single amino acids. They are useful in medicine and industrial processes, where they...
-
AI, Machine Learning & Computational Biology2 weeks agoIambic CEO on taking an AI drug company public
Fresh off a $150 million IPO, Tom Miller spoke to BioPharma Dive about the roadshow process and how he sees AI’s role in drug development evolving.
-
AI, Machine Learning & Computational Biology2 weeks ago13 AI drug discovery companies you should know about
Take a look at 13 of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process. The post...
-
AI, Machine Learning & Computational Biology2 weeks agoGenentech documentary celebrates 50th anniversary of biotech
A scientist and a financier walk into a bar… It sounds like the setup to a joke, but in the case of molecular biologist […] The...
-
AI, Machine Learning & Computational Biology2 weeks agoAI in drug discovery & development: News watch, October 2026
Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.
-
AI, Machine Learning & Computational Biology2 weeks agoNewly Identified Microexons Offer Clues to Autism Spectrum Disorder’s Genetic Roots
Hundreds of newly identified microexons seem to matter for autism and other neurological conditions, according to a Nature study. A machine learning model of their regulatory...
-
AI, Machine Learning & Computational Biology2 weeks agoIllumina Combines Multiomics Informatics Applications in New BioInsight Platform
Illumina is bringing its software, AI, and data offerings together in the new BioInsight platform, designed to help scientists analyze genomic and multiomic datasets. It will...
-
AI, Machine Learning & Computational Biology2 weeks agoIambic, an AI drug discovery specialist, banks $150M in an IPO
Part of a wave of young biotechs employing AI to accelerate research, the company claimed in regulatory filings that its approach has the potential to “disrupt...
LncRNA SBF2-AS1 Worsens Heart Injury After Attack via miR-149-5p/PHLPP2 Axis
Stigmatizing language found in over half of primary care patient records
Research report: The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
